Healio14d
FDA approves expanded label for Iluvien
The FDA approved an expanded label for Iluvien, which is now indicated for the treatment of chronic noninfectious uveitis ...
Pharmabiz1h
DORC’s ILM-Blue receives China NMPA approval; expanding global reach to prove high-quality and effective solutions to ophthalmic community
DORC’s ILM-Blue receives China NMPA approval; expanding global reach to prove high-quality and effective solutions to ophthalmic community: Jena, Germany Saturday, March 29, 202 ...
Healio1d
Top 5 MI ECG Patterns You Must Know
If this is the case, then the ST segment elevation will be in V3 to V6 — and not the septal leads. Because the anatomical opposite of the precordial leads would be posterior leads, which we do ...
Pharmabiz12d
US FDA approves expanded label for ANI Pharma’s Iluvien to treat chronic non-infectious uveitis affecting the posterior segment of the eye
US FDA approves expanded label for ANI Pharma’s Iluvien to treat chronic non-infectious uveitis affecting the posterior segment of the eye: Baudette, Minnesota Monday, March 17, ...
MPR10d
Iluvien Approved for Chronic Non-Infectious Posterior Uveitis
The Food and Drug Administration (FDA) has approved Iluvien® (fluocinolone acetonide intravitreal implant) for the treatment of chronic non-infectious ...
Taiwan News14d
ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label
Nikhil Lalwani, President and CEO of ANI stated, “ILUVIEN’s expanded label and the strengthening of our partnership with long-standing ILUVIEN contract manufacturer, Seigfried, will enhance supply ...